Integrilin

Active Ingredient(s): Eptifibatide
FDA Approved: * May 18, 1998
Pharm Company: * SCHERING
Category: Intravenous (IV) Therapy

Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein (P22827) found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Integrilin .75 mg/ml Intravenous Injection, Solution
NDC: 0085-1136
Labeler:
Merck Sharp & Dohme Corp.
Integrilin 2 mg/ml Intravenous Injection, Solution
NDC: 0085-1177
Labeler:
Merck Sharp & Dohme Corp.

Popular Topics

integrilin

miocardial infarction...